Pure Global

R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances - Trial NCT05876533

Access comprehensive clinical trial information for NCT05876533 through Pure Global AI's free database. This phase not specified trial is sponsored by Cordio Medical and is currently Recruiting. The study focuses on Chronic Heart Failure. Target enrollment is 250 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05876533
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT05876533
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances
An Observational, Retrospective, Single-arm, Open US and Israel Study , for Usability Assessment and Algorithm, Development of the Cordio HearO™ Systeam

Study Focus

Chronic Heart Failure

Cordio HearO

Observational

device

Sponsor & Location

Cordio Medical

South Windsor,Athens,Ashkelon,Be'er Sheva,Petah tikva, Israel,United States of America

Timeline & Enrollment

N/A

Mar 18, 2022

Sep 30, 2024

250 participants

Primary Outcome

Patient Usability success defined as: 1.Total and individual usability score of ≥3 in the usability questionnaire in ≥80% of the users.,Patient Usability success defined as: 2. Total Compliance

Summary

To determine the usability and technical aspects of Cordio HearO™

ICD-10 Classifications

Heart failure
Heart failure, unspecified
Congestive heart failure
Hypertensive heart disease with (congestive) heart failure
Hypertensive heart disease without (congestive) heart failure

Data Source

ClinicalTrials.gov

NCT05876533

Device Trial